Global Antiviral Drugs Market by Application - (HIV/AIDS, Hepatitis, Herpes, Influenza, and Others), by Target - (DNA Polymerase, NS3 Protease, Reverse Transcriptase, and Others), by End Users (Hospitals, Research Institutes, and Laboratory Centers), and by Region - Global Industry Analysis, Size, Share, Growth, Trends, and Forecasts (2016–2021)

Global Antiviral Drugs Market by Application - (HIV/AIDS, Hepatitis, Herpes, Influenza, and Others), by Target - (DNA Polymerase, NS3 Protease, Reverse Transcriptase, and Others), by End Users (Hospitals, Research Institutes, and Laboratory Centers), and by Region - Global Industry Analysis, Size, Share, Growth, Trends, and Forecasts (2016–2021)

ID: 1587 | Pages: 182 | November 2016 | Region: Global


The Global Antiviral Drugs Market is expected to reach USD 37.40 billion by 2021 from USD 29.16 billion in 2016, growing at a CAGR of 5.10% during the forecast period 2016-2021. Antiviral drugs are described as curative or disease controlling agents against viral infections. These drugs specifically attack viruses at different metabolic processes and alter the normal functioning of viral particles. From the past few years resistance is observed among viruses against different antiviral drugs with increasing diversity of viruses. This challenge leads to the evolution of broad spectrum antiviral drugs that specifically attack viruses at specified targets such as DNA Polymerase, NS3 Protease, & Reverse Transcriptase. These drugs are used to prevent or cure different viral infections such as HIV/AIDS, Hepatitis, influenza, and other viral infections.

The growth of Antiviral Drugs market is majorly driven by factors such as increase in public awareness, rise in healthcare expenditure, boost in Research and Development segment, emergence of life-threatening diseases, growing interest to support the development of novel antiviral drugs, existence of well-established supply chain. In addition, increasing incidence rates of viral infections is also fuelling the antiviral drugs market growth, such as according to World Health Organization, HIV/AIDS continues to be the major threat claiming more than 35 million lives so far. Globally, approximately 1.1 million lost their lives due to HIV in 2015. Approximately, 36.7 million people have been suffering from HIV in 2015. Furthermore, as late stage pipeline drugs are anticipated to hit the market, this further supports the antiviral drugs market growth. The key restraints of the market are high cost involved in drug development, increase in demand for alternative medicines (naturopathy, homeopathy, and oriental medicines), growing resistance among viruses against different antiviral drugs causing difficulty in developing broad-spectrum anti-viral drugs, restricted trade policies, lack of incentivization, and side-effects of products (nausea, diarrhea, and behavioral changes).

The global Antiviral Drugs Market is segmented on the basis of Application, Target, and End-Users. Based on Application, the market is classified into HIV/AIDS, Hepatitis, Herpes, Influenza, and Others. On the basis of Target, the market is classified into DNA Polymerase, NS3 Protease, Reverse Transcriptase, and Others. On the basis of End-Users, the market is classified into Hospitals, Research Institutes, and Laboratory Centers.

The market has also been geographically segmented into North America, Europe, Asia-Pacific and the Middle-East and Africa. North America is expected to command the major market share of 34.0% in the global antiviral drugs market. Whereas, Asia-Pacific is projected to grow at the highest CAGR of 6.12% during forecast period 2016-2021.

The major companies dominating the global Antiviral Drugs market are Johnson & Johnson (USA), Novartis International AG (Switzerland), Roche Holding AG (Switzerland), Pfizer (USA), Merck and Co. Inc (USA), GlaxoSmithKline plc (United Kingdom), AstraZeneca AB (United Kingdom), Gilead Sciences (USA), and Abbott Laboratories (USA).

 

1.Introduction                  

                1.1 Market Definition    

                1.2 Study Deliverables  

                1.3 Base Currency, Base Year and Forecast Periods           

                1.4 General Study Assumptions

2. Research Methodology                           

                2.1 Introduction              

                2.2 Research Phases      

                                2.2.1 Secondary Research

                                2.2.2 Primary Research

                                2.2.3 Econometric Modelling

                                2.2.4 Expert Validation

                2.3 Analysis Design         

                2.4 Study Timeline          

3. Overview                      

                3.1 Executive Summary

                3.2 Key Inferences         

                3.3 Epidemology             

4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)                      

                4.1 Market Drivers          

                4.2 Market Restraints    

                4.3 Key Challenges         

                4.4 Current Opportunities in the Market

5. Market Segmentation                              

                5.1 Application 

                                5.1.1 Introduction

                                5.1.2 HIV/AIDS

                                5.1.3 Hepatitis

                                5.1.4 Herpes

                                5.1.5 Influenza

                                5.1.6 Others

                                5.1.7 Y-o-Y Growth Analysis, By Application

                                5.1.8 Market Attractiveness Analysis, By Application

                                5.1.9 Market Share Analysis, By Application

                5.2 Target           

                                5.2.1 Introduction

                                5.2.2 DNA polymerase

                                5.2.3 NS3 Protease

                                5.2.4 Reverse transcriptase

                                5.2.5 Others

                                5.2.6 Y-o-Y Growth Analysis, By Target

                                5.2.7 Market Attractiveness Analysis, By Target

                                5.2.8 Market Share Analysis, By Target

                5.3 End Users    

                                5.3.1 Introduction

                                5.3.2 Hospitals/Clinics

                                5.3.3 Research Institutes

                                5.3.4 Laboratory Centers

                                5.3.5 Y-o-Y Growth Analysis, By End Users

                                5.3.6 Market Attractiveness Analysis, By End Users

                                5.3.7 Market Share Analysis, By End Users

6. Geographical Analysis                              

                6.1 Introduction              

                                6.1.1 Regional Trends

                                6.1.2 Impact Analysis

                                6.1.3 Y-o-Y Growth Analysis

                               

                               

                               

                               

                                6.1.4 Market Attractiveness Analysis

                               

                               

                               

                               

                                6.1.5 Market Share Analysis

                               

                               

                               

                               

                6.2 North America          

                                6.1.1 Introduction

                                6.1.2 United States

                                6.1.3 Canada 

                6.3 Europe         

                                6.2.1 Introduction

                                6.2.2 U.K

                                6.2.3 Spain

                                6.2.4 Germany

                                6.2.5 Italy 

                                6.2.6 France

                6.4 Asia-Pacific 

                                6.3.1 Introduction

                                6.3.2 China 

                                6.3.3 India 

                                6.3.4 Japan 

                                6.3.5 Australia

                                6.3.6 South Korea

                6.5 Latin America            

                                6.4.1 Introduction

                                6.4.2 Brazil

                                6.4.3 Argentina

                                6.4.4 Mexico

                                6.4.5 Rest of Latin America

                6.6 Middle East & Africa

                                6.5.1 Introduction

                                6.5.2 Middle-East

                                6.5.3 Africa

7.Strategic Analysis                        

                7.1 PESTLE analysis         

                                7.1.1 Political

                                7.1.2 Economic

                                7.1.3 Social

                                7.1.4 Technological

                                7.1.5 Legal

                                7.1.6 Environmental

                7.2 Porter’s Five analysis              

                                7.2.1 Bargaining Power of Suppliers

                                7.2.2 Bargaining Power of Consumers

                                7.2.3 Threat of New Entrants

                                7.2.4 Threat of Substitute Products and Services

                                7.2.5 Competitive Rivalry within the Industry

8.Market Leaders' Analysis                          

                8.1 Johnson & Johnson 

                                8.1.1 Overview

                                8.1.2 Product Analysis

                                8.1.3 Financial analysis

                                8.1.4 Recent Developments

                                8.1.5 SWOT analysis

                                8.1.6 Analyst View

                8.2 Novartis International AG     

                8.3 Roche Holding AG   

                8.4 Pfizer            

                8.5 Merck and Co. Inc    

                8.6 GlaxoSmithKline plc

                8.7 AstraZeneca AB        

                8.8 Gilead Sciences         

                8.9 Abbott Laboratories

9.Competitive Landscape                            

                9.1 Market share analysis            

                9.2 Merger and Acquisition Analysis        

                9.3 Agreements, collaborations and Joint Ventures          

                9.4 New Product Launches          

10.Market Outlook and Investment Opportunities                           

Appendix                           

                a) List of Tables

                b) List of Figures              

  • Global, Regional and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped
  • Segment-level analysis in terms of technology, component, and type along with market size forecasts and estimations to detect key areas of industry growth in detail
  • Identification of key drivers, restraints, opportunities, and challenges (DROC) in the market and their impact on shifting market dynamics
  • Study of the effect of exogenous and endogenous factors that affect the global market; which includes broadly demographic, economics, and political, among other macro-environmental factors presented in an extensive PESTLE Analysis
  • Study the micro environment factors that determine the overall profitability of an Industry, using Porter’s five forces analysis for analysing the level of competition and business strategy development
  • A comprehensive list of key market players along with their product portfolio, current strategic interests, key financial information, legal issues, SWOT analysis and analyst overview to study and sustain the market environment
  • Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies
  • An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis and main conclusions
  • Expertly devised analyst overview along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market
TitlePriceAdd To Cart
  1. Global Antiviral Drugs Market By Region, From 2016-2021 ( USD Billion )
  2. Global Antiviral Drugs Market By Application, From 2016-2021 ( USD Billion )
  3. Global HIV/AIDS  Market By Region, From 2016-2021 ( USD Billion )
  4. Global Hepatitis Market By Region, From 2016-2021 ( USD Billion )
  5. Global Herpes Market By Region, From 2016-2021 ( USD Billion )
  6. Global Influenza Market By Region, From 2016-2021 ( USD Billion )
  7. Global Others Market By Region, From 2016-2021 ( USD Billion )
  8. Global Antiviral Drugs Market By Target, From 2016-2021 ( USD Billion )
  9. Global DNA polymerase Market By Region, From 2016-2021 ( USD Billion )
  10. Global NS3 Protease Market By Region, From 2016-2021 ( USD Billion )
  11. Global Reverse transcriptase Market By Region, From 2016-2021 ( USD Billion )
  12. Global Others Market By Region, From 2016-2021 ( USD Billion )
  13. Global Antiviral Drugs Market By End User, From 2016-2021 ( USD Billion )
  14. Global Hospitals/Clinics Market By Region, From 2016-2021 ( USD Billion )
  15. Global Research Institutes Market By Region, From 2016-2021 ( USD Billion )
  16. Global Laboratory Centers Market By Region, From 2016-2021 ( USD Billion )
Middle East And Africa Western Blotting Market By Product (Instruments, Consumables), Application (Biomedical & Biochemical Research, Disease Diagnostics), End User (Academic & Research Institutes, Pharmaceutical & ...
Latin America Western Blotting Market By Product (Instruments, Consumables), Application (Biomedical & Biochemical Research, Disease Diagnostics), End User (Academic & Research Institutes, Pharmaceutical & Biotechno...
Asia Pacific Western Blotting Market By Product (Instruments, Consumables), Application (Biomedical & Biochemical Research, Disease Diagnostics), End User (Academic & Research Institutes, Pharmaceutical & Biotechnol...
Europe Western Blotting Market By Product (Instruments, Consumables), Application (Biomedical & Biochemical Research, Disease Diagnostics), End User (Academic & Research Institutes, Pharmaceutical & Biotechnology Co...
North America Western Blotting Market By Product (Instruments, Consumables), Application (Biomedical & Biochemical Research, Disease Diagnostics), End User (Academic & Research Institutes, Pharmaceutical & Biotechno...
Western Blotting Market By Product (Instruments, Consumables), Application (Biomedical & Biochemical Research, Disease Diagnostics), End User (Academic & Research Institutes, Pharmaceutical & Biotechnology Companies...
Middle East And Africa Multiplex Assays Market By Product (Consumable, Kits & Reagents, Panels), Type (nucleic Acid-Based, Protein-Based), Technology (PCR, Multiplex Array), Application (R&D, Companion Diagnostics),...
Latin America Multiplex Assays Market By Product (Consumable, Kits & Reagents, Panels), Type (nucleic Acid-Based, Protein-Based), Technology (PCR, Multiplex Array), Application (R&D, Companion Diagnostics), End User...
Asia Pacific Multiplex Assays Market By Product (Consumable, Kits & Reagents, Panels), Type (nucleic Acid-Based, Protein-Based), Technology (PCR, Multiplex Array), Application (R&D, Companion Diagnostics), End User ...
Europe Multiplex Assays Market By Product (Consumable, Kits & Reagents, Panels), Type (nucleic Acid-Based, Protein-Based), Technology (PCR, Multiplex Array), Application (R&D, Companion Diagnostics), End User (Hospi...
North America Multiplex Assays Market By Product (Consumable, Kits & Reagents, Panels), Type (nucleic Acid-Based, Protein-Based), Technology (PCR, Multiplex Array), Application (R&D, Companion Diagnostics), End User...
Multiplex Assays Market By Product (Consumable, Kits & Reagents, Panels), Type (nucleic Acid-Based, Protein-Based), Technology (PCR, Multiplex Array), Application (R&D, Companion Diagnostics), End User (Hospital, Cl...

"We Think Through Different Layers, We Work Across Different Verticals."

Market Data Forecast, Inc.
2nd Floor, Lakeview Plaza, Kavuri Hills, Hyderabad, Telangana 500033, India.
+1-888-702-9626 (U.S. TOLL FREE)
contact@marketdataforecast.com


Subscribe To Our News Letter

Or follow us on social platform

© 2017 Market Data Forecast
All Rights Reserved.